Since Fong first reported that SPRY2 was down-regulated and inhibited proliferation in HCC in 2006, there were many studies confirmed that SPRY2 inactivation was powerful for hepatocarcinogenesis, but no study involved in HCC progression35,36. This evidence concerns the gene SPRY2 and hepatocellular carcinoma.